These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9105844

  • 1. In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycin.
    Barry AL, Fuchs PC, Brown SD.
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):155-8. PubMed ID: 9105844
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
    Barry AL, Fuchs PC, Brown SD.
    J Antimicrob Chemother; 1998 Nov; 42(5):651-5. PubMed ID: 9848451
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group.
    Putnam SD, Jones RN, Johnson DM.
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):139-47. PubMed ID: 9294704
    [Abstract] [Full Text] [Related]

  • 5. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
    Jorgensen JH, McElmeel ML.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():69-73. PubMed ID: 9511067
    [Abstract] [Full Text] [Related]

  • 6. Quinupristin-dalfopristin.
    Bryson HM, Spencer CM.
    Drugs; 1996 Sep; 52(3):406-15. PubMed ID: 8875130
    [Abstract] [Full Text] [Related]

  • 7. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
    Lamb HM, Figgitt DP, Faulds D.
    Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
    [Abstract] [Full Text] [Related]

  • 8. Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristin.
    Tenover FC, Baker CN.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():81-5. PubMed ID: 9511069
    [Abstract] [Full Text] [Related]

  • 9. Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results.
    King A, May J, Phillips I.
    J Antimicrob Chemother; 1998 Dec; 42(6):711-9. PubMed ID: 10052893
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates.
    Qadri SM, Ueno Y, Abu Mostafa FM, Halim M.
    Chemotherapy; 1997 Dec; 43(2):94-9. PubMed ID: 9084917
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.
    Finch RG.
    Drugs; 1996 May; 51 Suppl 1():31-7. PubMed ID: 8724814
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.
    Izumikawa K, Hirakata Y, Yamaguchi T, Yoshida R, Tanaka H, Takemura H, Maesaki S, Tomono K, Kaku M, Izumikawa KI, Kamihira S, Kohno S.
    Antimicrob Agents Chemother; 1998 Mar; 42(3):698-9. PubMed ID: 9517955
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A, Lion C, Mory F, Weber M.
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [Abstract] [Full Text] [Related]

  • 17. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
    Schouten MA, Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Aug; 40(2):213-9. PubMed ID: 9301986
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK, Fung KS, Cheng AF.
    Chemotherapy; 2001 Aug; 47(4):243-9. PubMed ID: 11399860
    [Abstract] [Full Text] [Related]

  • 20. Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3028-31. PubMed ID: 9797249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.